Session

Follow us

SAVE THE DATE
  

SESSION

GEFVB – SESSION 1 – IMMUNOTHERAPY IN INTERMEDIATE-STAGE HCC: FROM CLINICAL CHALLENGES TO OPTIMIZING HOSPITAL PATHWAYS


MORE ON THE SESSION

  DATE: 19-11-2026


  TIME: 17:30 / 18:05


  DURATION: 35 minutes


  LOCATION: Room A


MODERATOR(S)

  • Tiago Pereira, Trofa Saúde | ULSEDV
  • José Presa Ramos, ULSTMAD
  • Tânia Rodrigues, Hospital da Luz Lisboa



LECTURE(S)

New Clinical Challenges in the Treatment of Intermediate-Stage HCC

  • Paula Jacinto, ULS Coimbra

How to adapt hospital pathways to the new therapeutic landscape

  • Pedro Sousa, Instituto Radiologia Pinto Leite

Discussion